SPANXN2 functions a cell migration inhibitor in testicular germ cell tumor cells

Fang Zhu1, Hao Bo1,2, Guangmin Liu1

  • 1Institute of Reproductive & Stem Cell Engineering, School of Basic MedicalScience, Central South University, Changsha, Hunan, China.

Peerj
|July 3, 2020
PubMed
Abstract

Insights

SPANXN2 gene expression is reduced in testicular germ cell tumors (TGCTs). Overexpressing SPANXN2 inhibits TGCT cell migration and proliferation by downregulating EMT and AKT signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • SPANX family genes are implicated in cancer progression.
  • Testicular germ cell tumors (TGCTs) are common in young men with poor prognosis.
  • The role of SPANXN2 in TGCT development is largely unknown.

Purpose of the Study:

  • To investigate the expression and function of SPANXN2 in TGCT.
  • To determine the potential of SPANXN2 as a prognostic indicator for TGCT.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) to analyze SPANXN2 expression in TGCT samples.
  • In vitro assays (transwell, wound healing, colony formation, MTT, cell cycle) to assess the impact of SPANXN2 overexpression on TGCT cell behavior.
  • Western blotting to examine the expression of epithelial-mesenchymal transition (EMT) and AKT pathway-related proteins.

Main Results:

  • SPANXN2 expression was found to be downregulated in TGCT samples compared to adjacent normal tissues.
  • Overexpression of SPANXN2 significantly reduced TGCT cell migration and colony formation.
  • SPANXN2 overexpression led to the downregulation of EMT markers (Vimentin, Snail) and AKT pathway proteins (AKT, p-AKT).

Conclusions:

  • SPANXN2 plays a role in regulating TGCT cell migration, likely through the modulation of EMT and AKT signaling pathways.
  • Further research is needed to fully elucidate the role of SPANXN2 in the occurrence and development of TGCT.